AC133 Antigen: Clinical Trials

2 trials of AC133 Antigen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2
Phase 21Completed 1

Follow AC133 Antigen: new trials by email Literature Review of AC133 Antigen trials Research Report on AC133 Antigen

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bone Marrow Derived AC 133+ and Mono-Nuclear Cells (MNC) Implantation in Myocardial Infarction (MI) Patient
AC133, MNC, CONTROL - Myocardial Infarction
Phase 2 / Phase 3CompletedRoyan Institute802009-05-012012-12-27
Autologous Bone Marrow Derived Stem Cells for Acute Myocardial Infarction
MNC, AC 133, Control - Myocardial Infarction
Phase 3CompletedRoyan Institute902008-01-012016-06-21

Conditions studied

Myocardial Infarction (2)

Sponsors

Royan Institute (2)

Countries

Iran (2)

Top investigators

Hamid Gourabi, PhD (2)  ·  Hossein Baharvand, PhD (2)  ·  Masoud Ghassemi, MD (1)  ·  Mohammadhassan Nasseri, MD (1)  ·  Nasser Aghdami, MD, PhD (1)  ·  Nasser Aghdami, PhD,MD (1)

Results publications

PMID 29633605